Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 366


Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP.

Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G.

Clin Orthop Relat Res. 2005 Aug;(437):48-54.


Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.

Dell'Acqua G, Giacometti A, Cirioni O, Ghiselli R, Saba V, Scalise G, Gov Y, Balaban N.

J Infect Dis. 2004 Jul 15;190(2):318-20. Epub 2004 Jun 24.


Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.

Balaban N, Cirioni O, Giacometti A, Ghiselli R, Braunstein JB, Silvestri C, Mocchegiani F, Saba V, Scalise G.

Antimicrob Agents Chemother. 2007 Jun;51(6):2226-9. Epub 2007 Mar 19.


Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.

Balaban N, Giacometti A, Cirioni O, Gov Y, Ghiselli R, Mocchegiani F, Viticchi C, Del Prete MS, Saba V, Scalise G, Dell'Acqua G.

J Infect Dis. 2003 Feb 15;187(4):625-30. Epub 2003 Feb 7.


BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci.

Domenico P, Gurzenda E, Giacometti A, Cirioni O, Ghiselli R, Orlando F, Korem M, Saba V, Scalise G, Balaban N.

Peptides. 2004 Dec;25(12):2047-53.


Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis.

Xu L, Li H, Vuong C, Vadyvaloo V, Wang J, Yao Y, Otto M, Gao Q.

Infect Immun. 2006 Jan;74(1):488-96.


A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci.

Balaban N, Gov Y, Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Orlando F, D'Amato G, Saba V, Scalise G, Bernes S, Mor A.

Antimicrob Agents Chemother. 2004 Jul;48(7):2544-50.


Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening.

Kiran MD, Adikesavan NV, Cirioni O, Giacometti A, Silvestri C, Scalise G, Ghiselli R, Saba V, Orlando F, Shoham M, Balaban N.

Mol Pharmacol. 2008 May;73(5):1578-86. doi: 10.1124/mol.107.044164. Epub 2008 Feb 26.


Biofilm in implant infections: its production and regulation.

Costerton JW, Montanaro L, Arciola CR.

Int J Artif Organs. 2005 Nov;28(11):1062-8. Review.


RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.

Ghiselli R, Giacometti A, Cirioni O, Dell'Acqua G, Mocchegiani F, Orlando F, D'Amato G, Rocchi M, Scalise G, Saba V.

Eur J Vasc Endovasc Surg. 2004 Jun;27(6):603-7.


Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors.

Kiran MD, Giacometti A, Cirioni O, Balaban N.

Int J Artif Organs. 2008 Sep;31(9):761-70. Review.


Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections.

Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, Scherpe S, Davies AP, Harris LG, Horstkotte MA, Knobloch JK, Ragunath C, Kaplan JB, Mack D.

Biomaterials. 2007 Mar;28(9):1711-20. Epub 2006 Dec 21.


RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.

Giacometti A, Cirioni O, Gov Y, Ghiselli R, Del Prete MS, Mocchegiani F, Saba V, Orlando F, Scalise G, Balaban N, Dell'Acqua G.

Antimicrob Agents Chemother. 2003 Jun;47(6):1979-83.


RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection.

Cirioni O, Ghiselli R, Minardi D, Orlando F, Mocchegiani F, Silvestri C, Muzzonigro G, Saba V, Scalise G, Balaban N, Giacometti A.

Antimicrob Agents Chemother. 2007 Dec;51(12):4518-20. Epub 2007 Sep 17.


Molecular genetics of Staphylococcus epidermidis biofilms on indwelling medical devices.

Vadyvaloo V, Otto M.

Int J Artif Organs. 2005 Nov;28(11):1069-78. Review.


Role of ClpP in biofilm formation and virulence of Staphylococcus epidermidis.

Wang C, Li M, Dong D, Wang J, Ren J, Otto M, Gao Q.

Microbes Infect. 2007 Sep;9(11):1376-83. Epub 2007 Jul 13.


The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.

Cirioni O, Giacometti A, Ghiselli R, Kamysz W, Silvestri C, Orlando F, Mocchegiani F, Vittoria AD, Kamysz E, Saba V, Scalise G.

Peptides. 2007 Jun;28(6):1299-303. Epub 2007 Mar 31.


Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.

Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Gov Y, Kamysz W, Lukasiak J, Mocchegiani F, Orlando F, D'Amato G, Balaban N, Saba V, Scalise G.

Circulation. 2003 Aug 12;108(6):767-71. Epub 2003 Jul 28.


RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.

Anguita-Alonso P, Giacometti A, Cirioni O, Ghiselli R, Orlando F, Saba V, Scalise G, Sevo M, Tuzova M, Patel R, Balaban N.

Antimicrob Agents Chemother. 2007 Jul;51(7):2594-6. Epub 2006 Nov 20.


Quorum-sensing control of biofilm factors in Staphylococcus epidermidis.

Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M.

J Infect Dis. 2003 Sep 1;188(5):706-18. Epub 2003 Aug 11.

Items per page

Supplemental Content

Write to the Help Desk